Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kavya Prasad
Observed name:
K Prasad
Institution:
Icahn School of Medicine at Mount Sinai
Observed institutions:
Memorial Sloan Kettering Cancer Center,
University of Pennsylvania,
Icahn School of Medicine at Mount Sinai
ORCID:
0000-0001-9583-9877
Observed ORCID:
0000-0001-9583-9877
OpenAlex ID:
A5032862365
Substantial External Dose Rate Variability Observed in a Cohort of Lu-177 Patients Independent of Bmi and Sex
2022
·
Michael Bellamy
, Bae Chu
, et al.
·
Radiation Protection Dosimetry
·
14
PDF
Radioactive seed localization is a safe and effective tool for breast cancer surgery: an evaluation of over 25,000 cases
2024
·
D Miodownik
, D Bierman
, et al.
·
Journal of Radiological Protection
·
10
Theranostic Intratumoral Convection-Enhanced Delivery of124I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry
2024
·
Neeta Pandit-Taskar
, Pat B. Zanzonico
, et al.
·
Journal of Nuclear Medicine
·
8
PDF
TRLS-07. Intracavitary carrier-embedded Cs131 brachytherapy for recurrent brain metastases: A randomized phase II study
2021
·
Nelson S Moss
, Brandon S Imber
, et al.
·
Neuro-Oncology Advances
·
8
Patient‐specific radiological protection precautions following Cs collagen embedded Cs‐131 implantation in the brain
2022
·
Kavya Prasad
, Lawrence T. Dauer
, et al.
·
Journal of Applied Clinical Medical Physics
·
5
Abstract PS18-06: Primary results and the transcriptomic analysis of PELOPS, a randomized phase II study of neoadjuvant palbociclib with or without endocrine therapy for breast cancer patients with invasive lobular carcinoma or invasive ductal carcinoma
2025
·
Rinath Jeselsohn
, Douglas Russo
, et al.
·
Clinical Cancer Research
·
4
Feasibility of safe outpatient treatment in pediatric patients following intraventricular radioimmunotherapy with 131I-omburtamab for leptomeningeal disease
2024
·
Kavya Prasad
, Brian E. Serencsits
, et al.
·
EJNMMI Research
·
3
Impact of shield location on staff and caregiver dose rates for I-131 radiopharmaceutical therapy patients
2023
·
M Bellamy
, B Chu
, et al.
·
Journal of Radiological Protection
·
2
PDF
69. PERMANENT INTRACAVITARY Cs131 BRACHYTHERAPY FOR PREVIOUSLY-IRRADIATED RECURRENT BRAIN METASTASES: INITIAL CLINICAL AND RADIATION SAFETY EXPERIENCE
2020
·
Nelson S Moss
, Brandon S Imber
, et al.
·
Neuro-Oncology Advances
·
1
Activins and BMPs: The yin and yang of diffuse midline gliomas
2026
·
Kavya Prasad
, Oren J. Becher
·
Cell stem cell
Optimizing Regulatory Reviews for Clinical Protocols That Use Radiopharmaceuticals: Findings of the University of Pennsylvania Radiation Research Safety Committee
2024
·
Sylvia S. Rhodes
, Janelle E. Jesikiewicz
, et al.
·
Health Physics
Show more works
View as search
Works count:
11
Citation count:
55
H-index:
5
I10-index:
2
Year
Topic
Type